The 2024 China Pharmaceutical Industry Development Conference and the Shanghai International Biomedical Industry Week opened on November 16 at the Zhangjiang Science Hall in Shanghai. During his speech, Zeng Yixin, Deputy Director of the National Health Commission, stated that the National Health Commission will fully implement the decisions and deployments of the 20th National Congress of the Communist Party, play a good role in the support and driving effect of technological innovation on the innovation and development of the pharmaceutical industry, and work to encourage application-oriented fundamental research, cutting-edge technology, clinical research, and demonstration promotion through coordination of major scientific projects and policies, striving for comprehensive improvement in the output of major original achievements, breakthroughs in key core technologies, and the construction of a talent system and research and development platform. (Shanghai Securities Journal)
国家卫生健康委:以重大科技项目和政策协同为抓手,力争在重大原创性成果产出等方面全面提升
National Health Commission: Taking major technology projects and policy coordination as a key focus, striving to comprehensively enhance major original achievements output and other aspects.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.